INTRODUCTION
As recently reported by several groups of investigators (1) (2) (3) , the plasma of totally depancreatized dogs contains normal, or even increased, quantities of a material immunometrically indistinguishable from pancreatic glucagon by radioimmunoassays regarded as highly specific for this hormone. As emphasized by Sasaki et al. (4) , this post-pancreatectomy immunoreactivity cannot be attributed to a cross reaction with high levels of "gut glucagon-like immunoreactivity", a group of immunometrically dissimilar poly-A preliminary note on part of this study was presented at Receivedfor publication 24 September 1976 and in revised form 3 December 1976. peptides whose level is not elevated after pancreatectomy (5) . However, glucagon cannot be detected in the blood of dogs that have undergone complete abdominal evisceration (6) . Therefore, in the dog, the origin of extrapancreatic glucagon is likely to be an abdominal organ; other significant sources of gluicagon, such as the salivary glands as reported in the rodents (7, 8) , are unlikely to exist.
Sutherland and De Duve (9) , almost 30 yr ago, were the first to suggest that glucagon may be present in the gastrointestinal tract. Since then, various groups (10) (11) (12) (13) (14) have reported that the oxyntic glandular mucosa ofthe canine stomach contains cells resembling pancreatic alpha(A) cells. The joint efforts of Unger's group in Dallas and Orci and his co-workers in Geneva established the presence in the gastrointestinal tract of a material biologically, physicochemically, and immunometrically identical to pancreatic glucagon (4) and also established the existence of A cells in the dog gastric fundus (4, 15) .
Because of the difficulty involved in the selective investigation of gastric glucagon secretion in pancreatectomized dogs, we designed an isolated perfused dog stomach system. The aim of the present study was to determine whether such an isolated system responds to the intravascular infusion of arginine by a release of gastric glucagon as does the pancreas, and whether such a response is affected by glucose, insulin, or somatostatin, which are all factors previously demonstrated to modify profoundly the secretion of pancreatic glucagon.
METHODS
Mongrel dogs of both sexes were fasted overnight and were anesthetized with pentobarbital (30 mg/kg). Large dogs, weighing 25-40 kg, were used as blood donors for loading the perfusion apparatus. Smaller dogs (7.5-15.0 kg) were used to provide the stomach. During the surgical procedure, the stomach-donor dogs were artificially ventilated with a mixture of oxygen (95%) and CO2 (5%).
After a large median xypho-pubic laparotomy, the stomach was completely isolated but its arterial and venotus supply was carefully preserved. The procedure included splenectomy, with ligature of all the splenic branches (rami lienalis) at the level of the long hilus but with careful preservation of the splenic and gastro-epiploic arteries; careful exclusion of all pancreatic tissue; dissection of the coeliac trunk and of the gastro-duodenal artery and vein; preservation of the right and left gastric artery and vein; and ligature and section of the hepatic pedicle. When the stomach was completely isolated with its arterial and venous supply, 5000 U of heparin (Boots Co, Nottingham, England) was injected intravenously. The cardia was then ligated and the esophagus was sectioned. A polyethylene catheter (outer diameter 1 cm; length 15 cm) was inserted into the stomach through the pylonis, which was then ligated.
The duodenum was sectioned right over the pylorus. A glass cannula of appropriate size was then inserted into the distal part of the coeliac trunk, which was tied and cut. Another glass cannula was inserted into the distal part of the portal vein to drain off all the venous blood leaving the stomach. After section of the portal vein, the stomach was completely isolated, removed from the abdominal cavity, and transferred to the perfusion machine. The duration of gastric ischemia (between the ligature of the arterial supply in situ and the beginning of the perfusion in vitro) never exceeded 4 min.
During the final stages of the isolation of the stomach, the perfusion machine was loaded with 1,100-1,200 ml of blood that was rapidly collected from both carotides of the blood donor. As previously shown necessary in this system (16) , the blood was supplemented with 1,000 U/ml Trasylol (Bayer, Leverkusen, W. Germany). The perfusion system was essentially the one designed by Nizet and his co-workers for the perfusion of isolated dog kidneys (17, 18) ; it consists basically of a film oxygenator and a Dale-Shuster pump under external hydraulic control. The whole system was kept at 38°C by a thermostatic bath. The blood was equilibrated with a gaseous mixture containing 95% 02 and 5% CO2. The blood flow through the stomach was measured either by means of a side-branched graduated 25-ml pipette and temporary occlusion of the venous return, or directly by collecting the venous effluent in graduated cylinders (16) . The arterial perfusion pressure in the isolated stomach was continuously measured with a mercury manometer and was adjusted if necessary by means of a Goldblatt clamp. Most perfusions were effected at a systolic pressure of 12-14 cm Hg. Stomach venous pressure was 2-4 cm H20. The output of gastric juice was collected in a graduated cylinder. Blood samples were simultaneously collected from the artery and the vein, and blood sampling started only after a 45-60-min equilibration period during which the blood was recirculated. Thereafter, samples were collected continuously at intervals of s, without recirculation of the blood, before, during and after an intraarterial infusion of Larginine monohydrochloride (Fluka AG, Buchs, Switzerland). The amino acid was diluted in saline and infused into the artery at a rate of 1 ml/min from time zero on, the concentration being adjusted to reach a final arginine concentration in the arterial plasma of about 10 mM; the arginine solution was therefore prepared extemporaneously after a preliminary determination of the flow and of the hematocrit of the blood perfuising the stomach in each particular experiment. In five experiments, arginine alone was infused.
In three experiments, a somatostatin infusion was started 10 min before the arginiine infuision and was continued until the end of the experiment. Linear somatostatin (Lot no 129 E 11-5 Roussel UCLAF, Paris, France), diluted in saline containing 0.25% human albumin, was infused into the artery at a rate of 0.2 ml/min, the concentration being adjusted to reach an arterial plasma somatostatin concentration of 100 ng/ml. In the last six perfusions, the blood perfusing the stomach was made hyperglycemic by the addition to the reservoir of sufficient 50% (wt/vol) glucose solution to allow a final blood glucose concentration of about 300 mg/100 ml. This addition was performed 30 min before the beginning of the arginine infusion. In three of these experiments, the blood reservoir was supplemented, 10 min before the arginine infusion, with an amount of insulin (Actrapid Novo, Novo Industries A/S, Copenhagen, Denmark; diluted in saline containing 1% crystallized bovine albumin) calculated to allow a final plasma insuilin concentration of about 120 ,uU/ml.
Blood glucose concentration was determined by the method of Hoffman (19) adapated to the Technicon AutoAnalyzer (Technicon Instruments Corp., Tarrytown, N. Y.). Plasma a-amino-nitrogen was determined by colorimetry (20) . For hormone assays, 0.4 ml of a solution containing Trasylol, 5,000 U/ml, and Na2EDTA, 12 mg/ml, was added to 3.6 ml of blood. The mixture was immediately centrifuged at 4°C and the separated plasma was stored at -20°C. Plasma glucagon was determined in duplicate assays by a classical radioimmunoassay procedure (21) , using porcine 1311-labeled glucagon as tracer, 30K antiserum (provided by Dr. R. H. Unger, Dallas, Tex.) and dextran-charcoal separation of free and antibody-bound hormone. Gastric-glucagon production by the stomach was calculated by multiplying the venoarterious difference in plasma glucagon concentration by the plasma flow (the latter being derived from the blood flow and the hematocrit). Plasma insulin was determined as previously described (22) . At the end of the experiment, the stomach was carefully dissected and weighed. In some preliminary experiments it was fixed for routine histologic examination.
RESULTS
Perfusion conditions and characteristics of the isolated perfused dog stomach. As shown in Table I , Table II . In all experiments, the stomach produced significant amounts of gastric juice during the equilibration period before arginine infusion. In most instances, the gastric juice was acidic; the total HCI output ranged from 0 to 0.9 meq/h. At the end of the perfusion the appearance of the stomach was normal on both its serous and mucous sides; however, a few histological controls demonstrated the presence of a moderate edema involving all layers. Gastric glucagon release tinder basal conditions. Immediately before arginine infusion, blood glucose and plasma a-amino-nitrogen were within the normal range: 72.7±4.0 mg/100 ml (n = 20) and 4.65±0.34 mg/100 ml (n = 17), respectively. Basal glucagon release averaged 7.0±3.0 ng/100 g stomach per 5 min (n = 7; range 0.0-15.5 ng/100 g per 5 min). In a single experiment, saline was infused at a rate of 1 ml/min into the artery for 10 min; under these conditions basal glucagon release averaged 4.5±0.5 ng/100 g per 5 min.
Gastric glucagon release in response to arginine infusion. As indicated under Methods arginine was infused at a rate calculated to reach an arterial plasma concentration of about 10 mM. Assuming that infused arginine is distributed solely in the plasma,' retrospective calculations on the basis of the actual plasma flows recorded in every experiment indicated that, in the 17 perfusion experiments reported here, the mean concentration of arginine in the arterial plasma was in fact 9.9 ± 0.3 mM. As indicated in Fig. 1 , plasma a-aminonitrogen concentrations in the venous effluent rose progressively, reached a plateau during the 3rd and the 5th min of the perfusion, and then declined abruptly after cessation of the infusion. By paired comparison, the first statistically significant rise in the venous-plasma concentration of a-aminonitrogen was obtained within 20-30 s after the beginning of the intraarterial infusion of arginine (9.6 ±1.9 mg/100 ml; P < 0.01). Comparison with dye infusion indicated that this delay corresponded almost entirely to the circulatory time in the system. As shown in Fig. 2 , arginine infusion resulted in rapid rise in glucagon output. Glucagon output began to increase 30-40 s after the beginning of the intraarterial arginine infusion, reached a peak value at about 60 s and then declined progressively. A transient off-response was sometimes observed immediately after the cessation of the infusion. The total amount of glucagon released during the arginine infusion averaged 50.1±10.4 ng/100g per 5 min (Table III) , that is, 6-10 times more than the basal release.
Effect of somatostatin on the arginine-induced gastric glucagon release. As shown in Table III Table IV , the arginine-induced gastric glucagon release was unaffected by hyperglycemia of the perfusing blood. When such hyperglycemia was concomitant with an hyperinsulinemia of 115±20 AU/ml, arginine-induced gastric glucagon release was reduced by about 40%. As shown in Fig. 3 , no major difference in the kinetic of the release was observed under either condition.
DISCUSSION
The recent identification of "true A cells" (4, 15, 23) as well as the presence of glucagon (23) (24) (25) been reported to contain glucagon. It must be said, however, that the amount of glucagon reported in the dog salivary glands are extremely low as compared with other animal species such as rodents (7, 8) , a finding which is indirectly confirmed by the absence of circulating glucagon in abdominally eviscerated dogs (6) . Preliminary stuidies have been reported on the release of canine gastric glucagon in anesthetized animals with appropriate cannulation of the gastric veins (26) . A precise study of the mechanisms controlling gastric glticagon release would involve the use of an isolated perfused organ, a method wlhich has already provided invaltuable information on the control of pancreatic glucagon release (27, 28) . The sturgical procedure described here for the isolation of the stomiach can be carried otut witlhin 60-75 min by a sturgical team of two. The uise of a perfuision machinie, uitilizinig whole blood as a perfusion fluid and originally designed for the perfuision of isolated dog kidneys (16) (17) (18) , permitted uis to study the function of this isolated dog stomach. Controls indicated perfect oxygenation of the blood throughout the experiment. At the end of the perfusion, a moderate metabolic acidosis, partly duie to the accumulation of laatate, was recorded. This is probably due to lactate production by both the erythrocytes and the stomach since erythrocytes, but also digestive mucosa, are mainly known to exhibit significant anaerobic glycolysis (29) . Indications of the satisfactory behavior of the isolated perfulsed stomach incltu(le persistence of strong gastric contractions throughouit the experiment, significant production-of an acidic juice, and a nonnal macroscopic and microscopic appearance of the organ at the end of the perfusionl, apart from a moderate edema noticed on the histologic samples.
Under basal conditions, gastric glucagon release was absent or imiinimal, a finding which is in agreement with previous data obtained in the anesthetized dog (26) . The release of gastric glucagon increased markedly and rapidly after a short arginine infuision which reached a 10-mM conicenitration in the arterial plasma; this is indeed a stronig stimulus of' pancreatic glucagon secretion both in vivo (review in 30) and in vitro (31, 32) . Therefore, the increased plasma glucagon observed after arginine infusion in insulindeprived depancreatized dogs (3, 26, 33 ) is likely to be, at least in part, of gastric origin. The stimilationi of the release of gastric glucagon occurs within seconds after the arrival of' arginine at the A cells. The kinetics of the release have been studied only during a 5-min arginine inftusion; this is essentially due to ouir decision to avoid recirculation of blood during the infuision, and therefore the relatively limited amount of blood obtainable from a single donor dog for loading the perfusion machine and the relatively high blood flow through the isolated stomach limit the duration of the experiment. The possibility of a two-phase release of glucagon, one rapid and one more sustained, as described for the pancreas (31, 32), has not been investigated in the present experiments.
Somatostatin, which is a potent inhibitor of gltucagon secretion (34) , almost completely blocked the arginine-induced gastric glucagon release. This finding (44) mtust be accepted only if experimental data are provided of the total insulin lack of these patients at the time of study. Prolonged insuilin deprivation anid apl)ropriate assays of cireculating insuilin (47) slhowinig that inistulini lack is indeed complete are prere(qtuisites to the demonistration that there is no extrapancreatic souirce of gltucagon in manl.
Note added in proof. Since submission of this mantuscript, Mutioz-Barragan et al. (49) reported evidence that in normnal conscious (lo)gs, the gastric findtis is not a major souirce of gastric glulcagon, a finding in agreement with the low release of' gastric glucagon unlder basal conditionis reported above.
In contrast, Blaz(lquez et al. (50) reported th-at (a) in the insulin-deprived depancreatized dog, the stomiiach is a major souirce of gluicagon; (b) gastric glucagon secretion is stiinmmlated bv intravenous and intragastric arginine adm-ninistration; (c) it is not influienced by intravenouis or intragastric gltucose adminiistration; and (d) glicagon release is suppressecl by physiological levels of insuilin.
